{"investor":{"slug":"navis-capital-partners","name":"Navis Capital Partners","website":null,"x_handle":null,"logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9pbWFnZXMuY3J1bmNoYmFzZS5jb20vaW1hZ2UvdXBsb2FkL3YxMzk3MTc4NjQyLzY0NTg4YmY3NTViNzU0MTMyZDI0ZTljMDliZjA3MTBhLmpwZw","type":"fund","companies":1,"deals":0,"deals_12m":0,"deals_90d":0,"leads":0,"round_capital":0,"latest_deal":null},"profile":null,"fund_returns":[],"portfolio":[{"slug":"astrocyte-pharmaceuticals","name":"Astrocyte Pharmaceuticals","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9pbWFnZXMuY3J1bmNoYmFzZS5jb20vaW1hZ2UvdXBsb2FkL3YxNTAyODY0NDY1L2p3aHd3MDJ4a3ZqdXhvM3lrY2RnLnBuZw","crypto":false,"categories":["health-bio"],"total_raised":9500000,"latest_raise":{"date":"2023-08-18","stage":"series-b+","amount_usd":9500000,"source_url":"https://www.prnewswire.com/news-releases/astrocyte-pharmaceuticals-secures-9-5-million-series-b-to-advance-phase-2-clinical-development-of-breakthrough-tbi-and-concussion-therapy-ast-004--302893833.html"},"rounds_with_investor":[],"backer_source_url":null}],"top_categories":[{"key":"health-bio","label":"Health and bio","companies":1,"share":1}],"allocation":{"stages":[],"years":[]},"co_investors":[]}